Skip to content

Author

Mikołaj Roszkowski

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access 2026

Interpatient and intrapatient variability in organ absorbed doses during [177Lu]Lu-DOTATATE therapy for neuroendocrine tumors.

BACKGROUND Peptide receptor radionuclide therapy (PRRT) with lutetium-177 labeled somatostatin analogues is an established treatment for patients with advanced neuroendocrine tumors (NETs). There is growing evidence of a dose-response relationship. Considering critical organ exposure, most patients are treated with fix...

Małgorzata Poniatowska-Roszkowska, H. Piwowarska-Bilska, Mikołaj Roszkowski et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.